+49 (0)511 532 8736 Email: viejo-borbolla.abel @ mh-hannover.de About me (Abel Viejo-Borbolla): I studied Biological Sciences (specialized in Molecular Biology and Biochemistry) at the “Universidad Autónoma [...] my PhD research was to improve targeted retroviral vectors used in gene therapy. Then I started studying herpesviruses, working first with Kaposi’s sarcoma-associated herpesvirus in Thomas Schulz’s lab [...] l Virology and in 2019 I became an APL Professor. One of the best things of my career is that I studied and worked in very different environments in different countries. This allowed me to meet incredible

patients with progressive myocardial insufficiency because of myocardial infarction. In previous studies, the cells were injected manually into the recipient heart. In order to allow an optimized and b [...] the preclinical implementation of new cell therapy concepts, a review of the data from in vitro studies in the living organism is inevitable. Only suitable animal models allow such therapeutic applications [...] knowledge, preclinical testing of our therapeutic concept is only possible in non-human primates. Our studies in rhesus monkeys will be performed at the German Primate Center in Göttingen according to strict

Heinze B, Pfirrmann M, Holgado S, Schmeil A, Tobler A, Hasford J, Buhr T, Kreipe HH: German CML Study Group Treatment intensity significantly influencing fibrosis in bone marrow independently of the [...] the Evolution of Myelofibrosis in Pre-Fibrotic Chronic Idiopathic Myelofibrosis: A retrospective study based on follow up biopsies of 70 patients by using the RECPAM method. Leukemia Lymphoma 2004; 45(3): [...] Eimermacher H, Verbeek W, Kreipe HH, Heimpel H, Aul C, Ganser A: A prospective, randomized, phase II study of horse antithymocyte globulin vs rabbit antithymocyte globulin as immune-modulating therapy in patients

Practical year (6th year of study) In the 6th year of your studies, you will complete the practical year after passing the 2nd section of the medical examination. The PJ office looks after all students [...] university for the practical year If you would like to transfer to the MHH for the final stage of your studies, the Practical Year (PJ), you must first arrange a consultation with the PJ office. You must then

(SC)-based approaches have been proposed for heart repair, but a multitude of experimental and clinical studies applying various adult stem cells have not achieved functional improvement, or showed only minor [...] implant-related arrhythmias could be controlled through technical pacemaker devices. A promising study (published in 2014) demonstrated, for the first time, the formation and functional coupling of large [...] Old Word monkeys and are frequently used in pharmaceutical industry, e.g. for safety and efficacy studies for certain drug approval. Preclinical assessment of our cell therapy concept is crucial to cover

survival time of patients with newly diagnosed AML. This was the result of an international clinical study with the participation of Professor Dr. Michael Heuser, Senior Physician at the Department of Haematology

reasons for this and the strategies that can be used to overcome resistance to molecular treatment. The study has been published in the renowned journal "Hepatology". The first author is PhD student Gajanan Kendre

failure patients through his spin-of biotech company Cardior Pharmaceuticals GmbH (currently a phase II study is running). In 2024, Cardior was acquired by Novo Nordisk for >1 billion EUR. Additionally, Thum

Unimed joint project of the University Medicine Network Updated on 18.11.2020 With the OnCOVID II study "Participatory decision-making and ethical aspects of risk stratification and pandemic management"

Rehabilitation and Sports Medicine is the central point of contact at the MHH. Sports therapy Scientific studies show that regular exercise can reduce disease- and therapy-related stress. Sports therapy can improve